Amwell (AMWL) ebitda was -$38M in FY2025 (+67% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
-$38M
+67%
2024
-$116M
+80%
2023
-$589M
-226%
2022
-$181M
-51%
2021
-$119M
-21%
2020
-$99M
-32%
2019
-$75M
-78%
2018
-$42M
Recent Quarterly EBITDA
Quarter
EBITDA
Q2 2026
-$1M
Q1 2026
-$3M
Q4 2025
-$10M
Q3 2025
-$13M
Q2 2025
-$4M
Q1 2025
-$11M
Q4 2024
-$20M
Q3 2024
-$26M
Q2 2024
-$29M
Q1 2024
-$42M
Q4 2023
-$36M
Q3 2023
-$118M
Source: AMWL on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.